{
    "Trade/Device Name(s)": [
        "ACCU-CHEK Aviva Connect Blood Glucose Monitoring System",
        "ACCU-CHEK Aviva Connect Meter",
        "ACCU-CHEK Aviva Plus Test Strip",
        "ACCU-CHEK Aviva Control Solutions"
    ],
    "Submitter Information": "Roche Diagnostics Corporation",
    "510(k) Number": "K141867",
    "Predicate Device Reference 510(k) Number(s)": [
        "K133862"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "February 2, 2015",
    "Summary Letter Received Date": "February 3, 2015",
    "Submission Date": "February 6, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [
        "Test strip"
    ],
    "Instrument(s)/Platform(s)": [
        "ACCU-CHEK Aviva Connect Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for ACCU-CHEK Aviva Connect Blood Glucose Monitoring System for measuring glucose in fresh capillary whole blood samples via amperometric detection.",
    "Indications for Use Summary": "Intended for self-testing by people with diabetes at home for the quantitative measurement of glucose in fresh capillary whole blood from the fingertips; not for diagnosis, diabetes screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}